Literature DB >> 9635256

Expression of nitric oxide synthase isoforms in normal human tracheobronchial epithelial cells in vitro: dependence on retinoic acid and the state of differentiation.

D Norford1, J S Koo, T Gray, K Alder, P Nettesheim.   

Abstract

The retinoic acid (RA) and differentiation dependence of constitutive expression of the nitric oxide synthase (NOS) isoforms, iNOS, eNOS, and bNOS, was examined by reverse transcriptase polymerase chain recitation (RT-PCR) in cultured, normal, human, tracheobronchial epithelial (NHTBE) cells. In the presence of RA (RA+), early passage NHTBE cells grown in air-liquid interface (ALI) cultures undergo mucous differentiation; in the absence of RA (RA-), they undergo metaplastic squamous differentiation. Under both conditions the respective differentiated phenotype develops around day 10 of culture. We found that iNOS mRNA levels were much higher in RA+ cultures, expressing the mucous phenotype, than in RA- cultures, expressing the metaplastic squamous phenotype. In contrast, eNOS mRNA levels were much higher in RA- cultures than in RA+ cultures. Expression of bNOS was not significantly affected by the RA status. The pattern of expression of NOS isoforms was then studied during the course of development of the two cellular phenotypes. During the early stages of differentiation, expression of iNOS (RA+) and eNOS (RA-) was very low, indicating that the expression of these two isoforms was not only dependent on the presence or absence of RA, but also on the degree of differentiation. The differentiation dependence of bNOS mRNA was less obvious. Four days of RA treatment of RA- cultures, which reverses the squamous phenotype and restores mucous differentiation, induced iNOS expression in a concentration-dependent manner. eNOS expression was depressed by 10(-8) M RA, while bNOS mRNA levels were slightly reduced by 10(-6) M RA. No NOS proteins were detected in unstimulated RA+ and RA- cultures. iNOS protein was induced by cytokine treatment in RA+ cultures, in contrast to eNOS and bNOS protein levels, which were unaffected. Our studies show that constitutive expression of the NOS isoforms is differentially regulated and that iNOS and eNOS mRNA levels are dependent on the stage of mucous and squamous differentiation, respectively. bNOS expression was only marginally affected by the RA or differentiation status.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635256     DOI: 10.3109/01902149809041540

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  5 in total

1.  Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells.

Authors:  Vinod Suresh; Justin D Mih; Steven C George
Journal:  Am J Respir Cell Mol Biol       Date:  2007-03-08       Impact factor: 6.914

2.  RNA-Seq quantification of the human small airway epithelium transcriptome.

Authors:  Neil R Hackett; Marcus W Butler; Renat Shaykhiev; Jacqueline Salit; Larsson Omberg; Juan L Rodriguez-Flores; Jason G Mezey; Yael Strulovici-Barel; Guoqing Wang; Lukas Didon; Ronald G Crystal
Journal:  BMC Genomics       Date:  2012-02-29       Impact factor: 3.969

3.  Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitro.

Authors:  Brian N Chorley; Anne L Crews; Yuehua Li; Kenneth B Adler; Michael Minnicozzi; Linda D Martin
Journal:  Respir Res       Date:  2006-02-25

4.  Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells.

Authors:  Skyla T Carney; Michael L Lloyd; Shanta E MacKinnon; Doshandra C Newton; Jenelle D Jones; Allyn C Howlett; Derek C Norford
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-14       Impact factor: 4.147

5.  Interleukin-13 stimulates production of nitric oxide in cultured human nasal epithelium.

Authors:  Johnny L Carson; Michelle Hernandez; Ilona Jaspers; Katherine Mills; Luisa Brighton; Haibo Zhou; Jing Zhang; Milan J Hazucha
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-01-29       Impact factor: 2.416

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.